Cerus Corp (CERS)
6.13
-0.07 -1.13%
NASDAQ
Oct 15, 16:00
6.13
0.00 0.00%
After-Hours: 16:37
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 130.11M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.36 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -61.34M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 59.42% |
| Profit Margin (Quarterly) | -40.68% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 1.052B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 7.939 |
| PE Ratio | -- |
| Price to Book Value | 12.49 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.7599 |
| Free Cash Flow (Quarterly) | -8.174M |
| Return on Equity | Upgrade |
View All CERS News
News
-
WireHeadlineTime (ET)
-
Yahoo10/07 06:49
-
Yahoo10/01 08:00
-
Yahoo09/20 08:00
-
Yahoo09/15 08:00
-
Yahoo08/15 13:26
-
Yahoo08/10 08:30
-
MT Newswires08/04 17:34
-
MT Newswires08/04 15:49
-
MT Newswires08/04 14:48
-
SA Breaking News08/04 11:00
-
SA Breaking News08/04 10:15
-
PR Newswire08/04 08:45
-
Yahoo08/04 08:30
-
MT Newswires08/04 05:43
-
Yahoo08/04 05:01
-
Yahoo08/04 02:48
-
MT Newswires08/03 17:48
-
Yahoo08/03 17:15
-
MT Newswires08/03 16:23
-
MT Newswires08/03 16:00
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 10/29/2021 | Earnings Results | Q3 2021 Earnings Results |
| 10/29/2021 16:30 EST | Earnings Calls | Q3 2021 Earnings Call |
| 08/03/2021 | Earnings Results | Q2 2021 Earnings Results |
| 08/03/2021 16:30 EST | Earnings Calls | Q2 2021 Earnings Call |
| 06/02/2021 12:00 EST | AGM | 2020 Annual General Meeting |
| 05/04/2021 | Earnings Results | Q1 2021 Earnings Results |
| 05/04/2021 16:30 EST | Earnings Calls | Q1 2021 Earnings Call |
| 02/25/2021 | Earnings Results | Q4 2020 Earnings Results |
| 02/25/2021 16:30 EST | Earnings Calls | Q4 2020 Earnings Call |
| 10/29/2020 | Earnings Results | Q3 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
- URL: http://www.cerus.com
- Investor Relations URL: https://ir.cerus.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Oct. 29, 2021
- Last Earnings Release: Aug. 03, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 6.13 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| RBF20927 | RBC Private U.S. Small-Cap Eqty Pool F (USD) | 2.94% |
| PVIVX | Paradigm Micro-Cap | 2.11% |
| XHE | SPDR® S&P Health Care Equipment ETF | 1.29% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CERS Tweets Stocktwits
Advertisement
